DeltaNp63 Is a Protective Marker of Progression in HGT1 Bladder Cancer

被引：0
|
作者：
Castillo-Martin, M.
Sopena, J. M. Gaya
Gladoun, N.
Karni-Schmidt, O.
Gonzalez, C.
Algaba, F.
Redorta, J. Palou
Cordon-Cardo, C.
机构：
[1] Mt Sinai Med Ctr, Mt Sinai Sch Med, New York, NY 10029 USA
[2] Fundacio Puigvert, Barcelona, Spain
来源：
MODERN PATHOLOGY | 2013年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
823
引用
收藏
页码：199A / 200A
页数：2
相关论文
共 50 条
  • [31] A TWO-HIT MINIMALIST DIAGNOSTIC ALGORITHM BASED ON P40 (DELTANP63) AND TTF-1 IMMUNOSTAINING UPON SMALL BIOPSY/CELLBLOCK SAMPLES FOR DIFFERENTIATING MAIN SUBTYPES OF NON-SMALL CELL LUNG CANCER AND SPARING MATERIAL
    Pelosi, Giuseppe
    Fabbri, Alessandra
    Rossi, Giulio
    Maisonneuve, Patrick
    Sonzogni, Angelica
    Bresaola, Enrica
    Pastorino, Ugo
    Papotti, Mauro
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S335 - S336
  • [32] PLEKHS1: A new molecular marker predicting risk of progression of non-muscle-invasive bladder cancer
    Pignot, Geraldine
    Le Goux, Constance
    Vacher, Sophie
    Schnitzler, Anne
    Radvanyi, Francois
    Allory, Yves
    Lallemand, Francois
    Delongchamps, Nicolas Barry
    Zerbib, Marc
    Terris, Benoit
    Damotte, Diane
    Bieche, Ivan
    ONCOLOGY LETTERS, 2019, 18 (04) : 3471 - 3480
  • [33] Expression of Bmi-1 is a prognostic marker in bladder cancer
    Qin, Zi-Ke
    Yang, Jian-An
    Ye, Yun-lin
    Zhang, Xing
    Xu, Li-Hua
    Zhou, Fang-Jian
    Han, Hui
    Liu, Zuo-Wei
    Song, LI-Bing
    Zeng, Mu-Sheng
    BMC CANCER, 2009, 9
  • [34] CEACAM1 IS A NEW URINARY MARKER FOR BLADDER CANCER
    Tilki, Derya
    Singer, Bernhard B.
    Behrend, Andreas
    Buchner, Alexander
    Seitz, Michael
    Reich, Oliver
    Shariat, Shahrokh F.
    Stief, Christian G.
    Ergun, Suleyman
    JOURNAL OF UROLOGY, 2009, 181 (04): : 418 - 418
  • [35] Immunoreactivity for DeltaNp63-p40, a Basal-Type Marker, as a Holistic, Single-Shot Diagnostic Adjunct Approach to Morphology for Lung Cancer Subtyping
    Pelosi, G.
    Rossi, G.
    Cavazza, A.
    Righi, L.
    Pastorino, U.
    Scanagatta, P.
    Rekhtman, N.
    Sonzogni, A.
    Papotti, M.
    LABORATORY INVESTIGATION, 2012, 92 : 486A - 486A
  • [36] MUC1 mucin as a tumour marker in bladder cancer
    Simms, MS
    Hughes, ODM
    Limb, M
    Price, MR
    Bishop, MC
    BJU INTERNATIONAL, 1999, 84 (03) : 350 - 352
  • [37] Expression of Bmi-1 is a prognostic marker in bladder cancer
    Zi-Ke Qin
    Jian-An Yang
    Yun-lin Ye
    Xing Zhang
    Li-Hua Xu
    Fang-Jian Zhou
    Hui Han
    Zuo-Wei Liu
    Li-Bing Song
    Mu-Sheng Zeng
    BMC Cancer, 9
  • [38] Immunoreactivity for DeltaNp63-p40, a Basal-Type Marker, as a Holistic, Single-Shot Diagnostic Adjunct Approach to Morphology for Lung Cancer Subtyping
    Pelosi, G.
    Rossi, G.
    Cavazza, A.
    Righi, L.
    Pastorino, U.
    Scanagatta, P.
    Rekhanan, N.
    Sonzogni, A.
    Papotti, M.
    MODERN PATHOLOGY, 2012, 25 : 486A - 486A
  • [39] The interplay between the transcriptional factor p63 and lipase MGLL affects bladder cancer progression
    Canonico, M. Franzese
    Smirnov, A.
    Fanciulli, M.
    Mauriello, A.
    Melino, G.
    Candi, E.
    FEBS OPEN BIO, 2024, 14 : 273 - 273
  • [40] Distinct Expression Profiles of p63 Variants during Urothelial Development and Bladder Cancer Progression
    Karni-Schmidt, Orit
    Castillo-Martin, Mireia
    Shen, Tian Huai
    Gladoun, Nataliya
    Domingo-Domenech, Josep
    Sanchez-Carbayo, Marta
    Li, Yingchun
    Lowe, Scott
    Prives, Carol
    Cordon-Cardo, Carlos
    AMERICAN JOURNAL OF PATHOLOGY, 2011, 178 (03): : 1350 - 1360
12345